Page 54 - ITPS-7-4

INNOSC Theranostics and
Pharmacological Sciences Biomarkers and drugs in Africa

doi: 10.3390/pharmaceutics15061630 doi: 10.1016/j.tcm.2016.07.005
3. Azizi M, Kokabi H, Dianat-Moghadam H, Mehrmohammadi M. 14. Yang J, Nie J, Ma X, Wei Y, Peng Y, Wei X. Targeting PI3K
Challenges and future directions. In: Targeted Cancer Imaging. in cancer: Mechanisms and advances in clinical trials. Mol
Netherlands: Elsevier; 2022. p. 139-201. Cancer. 2019;18(1):26.
doi: 10.1016/B978-0-12-824513-2.00006-1 doi: 10.1186/s12943-019-0954-x
4. Agarwal S, Fang L, McGowen K, et al. Tumor-derived 15. FDA-NIH Biomarker Working Group. BEST (Biomarkers,
biomarkers beyond antigen expression enhance efficacy EndpointS, and other Tools) Resource. Silver Spring (MD):
of CD276/B7H3 antibody-drug conjugate in metastatic Food and Drug Administration (US); 2016. Available from:
prostate cancer. Cancer Biol. 2022. https://www.ncbi.nlm.nih.gov/books/NBK326791 [Last
doi: 10.1101/2022.04.19.488784 accessed on 2024 Nov 05].
5. Nagakura Y, Tozaki-Saitoh H, Takeda H. Drug discovery and 16. Chiu FY, Yen Y. Imaging biomarkers for clinical applications
development for fibromyalgia using practical biomarkers in neuro-oncology: Current status and future perspectives.
throughout the process from relevant animal models to Biomark Res. 2023;11(1):35.
patients. Expert Opin Drug Discov. 2023;18(5):539-549. doi: 10.1186/s40364-023-00476-7
doi: 10.1080/17460441.2023.2202908 17. Bodaghi A, Fattahi N, Ramazani A. Biomarkers: Promising
6. Kumar RR, Kumar A, Chuang CH, Shaikh MO. Recent and valuable tools towards diagnosis, prognosis and
advances and emerging trends in cancer biomarker detection treatment of Covid-19 and other diseases. Heliyon.
technologies. Ind Eng Chem Res. 2023;62(14):5691-5713. 2023;9(2):e13323.
doi: 10.1021/acs.iecr.2c04097 doi: 10.1016/j.heliyon.2023.e13323
7. Sahin TK, Rizzo A, Aksoy S, Guven DC. Prognostic 18. Badianyama M, Mpanya D, Adamu U, Sigauke F, Nel S,
significance of the royal marsden hospital (RMH) score in Tsabedze N. New biomarkers and their potential role in
patients with cancer: A systematic review and meta-analysis. heart failure treatment optimisation-an African perspective.
Cancers (Basel). 2024;16(10):1835. J Cardiovasc Dev Dis. 2022;9(10):335.
doi: 10.3390/cancers16101835 doi: 10.3390/jcdd9100335
8. Moore DC, Guinigundo AS. Revolutionizing cancer 19. Drugan T, Leucuța D. Evaluating novel biomarkers for
treatment: Harnessing the power of biomarkers to improve personalized medicine. Diagnostics (Basel). 2024;14(6):587.
patient outcomes. J Adv Pract Oncol. 2023;14(Suppl 1):4-8. doi: 10.3390/diagnostics14060587
doi: 10.6004/jadpro.2023.14.3.15 20. Islam SU, Ahmed MB, Ahsan H, Lee YS. Role of biomarkers
9. Al-Dewik NI, Younes SN, Essa MM, Pathak S, Qoronfleh in personalized medicine. In: Shehzad A, editors. Cancer
MW. Making biomarkers relevant to healthcare innovation Biomarkers in Diagnosis and Therapeutics. Berlin: Springer,
and precision medicine. Processes. 2022;10(6):1107. Singapore; 2022.
doi: 10.3390/pr10061107 doi: 10.1007/978-981-16-5759-7_10
10. Waeni JM, Chege T, Gicheru ET, et al. Discovery and 21. Francesqui J, Marrades P, Sellares J. Personalized medicine
validation of plasma-based protein biomarkers for the in sarcoidosis: Unravelling biomarkers for targeted care.
aetiological distinction of bacterial and non-bacterial febrile Curr Opin Pulm Med. 2023;29(5):478-484.
infections in African children. medRxiv. 2024:2024-01. doi: 10.1097/MCP.0000000000000985
doi: 10.1101/2024.01.10.24300882 22. Olichney J, Xia J, Church KJ, Moebius HJ. Predictive power
11. Guven DC, Erul E, Kaygusuz Y, et al. Immune checkpoint of cognitive biomarkers in neurodegenerative disease drug
inhibitor-related hearing loss: A systematic review and development: Utility of the P300 event-related potential.
analysis of individual patient data. Support Care Cancer. Neural Plast. 2022;2022:2104880.
2023;31(11):624. doi: 10.1155/2022/2104880
doi: 10.1007/s00520-023-08083-w 23. Sancandi M, Uysal-Onganer P, Kraev I, Mercer A, Lange S.
12. Califf RM. Biomarker definitions and their applications. Exp Protein deimination signatures in plasma and plasma-
Biol Med (Maywood). 2018;243(3):213-221. EVs and protein deimination in the brain vasculature in a
rat model of pre-motor Parkinson’s disease. Int J Mol Sci.
doi: 10.1177/1535370217750088
2020;21(8):2743.
13. Dhingra R, Vasan RS. Biomarkers in cardiovascular disease:
Statistical assessment and section on key novel heart failure doi: 10.3390/ijms21082743
biomarkers. Trends Cardiovasc Med. 2017;27(2):123-133. 24. Landeck L, Kneip C, Reischl J, Asadullah K. Biomarkers

Volume 7 Issue 4 (2024) 10 doi: 10.36922/itps.3656